P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV by Van Rompay K, Marthas ML, Patel V, Alicea C, von Gegerfelt A, Valentin A, Pavlakis GN, Felber BK

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites by Franchini G, Pavlakis GN, Felber BK, Gonzalez L, Fisher E, Kolber MA, Vaccari M, Pahwa S, Strbo N, Podack ER

DNA vaccines expressing conserved elements provide potent and broad immune responses by Pavlakis GN, Kulkarni V, Valentin A, Rosati M, Sardesai NY, Mothe B, Brander C, LeGall S, Weiner DB, Rolland M, Mullins JI, Felber BK

P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors by Rosati M, Alicea C, Patel V, Kulkarni V, Jalah R, von Gegerfelt A, Valentin A, Felber BK, Khan A, Draghia-Akli R, Pavlakis GN

P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge by Khan A, Ohlen C, von Gegerfelt A, Jalah R, Kulkarni V, Bergamaschi C, Valentin A, Patel V, Rosati M, Pavlakis GN, Draghia-Akli R, Van Rompay K, Felber BK